Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Sees Significant Drop in Short Interest

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 953,172 shares, a decrease of 40.2% from the March 31st total of 1,594,722 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Shanghai Fosun Pharmaceutical (Group) Price Performance

SFOSF opened at $2.60 on Monday. Shanghai Fosun Pharmaceutical has a 1-year low of $1.62 and a 1-year high of $3.50. The company’s 50 day simple moving average is $2.57 and its two-hundred day simple moving average is $2.88.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.